Validation of TDP-43 Splicing Repression as a Therapeutic Strategy for ALS and FTD

Postdoctoral Fellow at Johns Hopkins School of Medicine studying TDP-43 loss of function and developing splicing-based therapies for ALS and frontotemporal dementia.